Leerink Partnrs Comments on Henry Schein, Inc.’s Q1 2025 Earnings (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for Henry Schein in a research note issued to investors on Monday, October 14th. Leerink Partnrs analyst M. Cherny forecasts that the company will earn $1.20 per share for the quarter. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q2 2025 earnings at $1.32 EPS, Q3 2025 earnings at $1.33 EPS and Q4 2025 earnings at $1.46 EPS.

Several other brokerages have also recently issued reports on HSIC. Evercore ISI raised their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Friday, September 20th. Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Piper Sandler reissued an “overweight” rating and issued a $86.00 target price on shares of Henry Schein in a report on Friday, June 21st. Finally, JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. One analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $77.50.

Henry Schein Price Performance

Shares of HSIC opened at $71.10 on Wednesday. Henry Schein has a 52 week low of $60.01 and a 52 week high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The firm has a market cap of $9.10 billion, a price-to-earnings ratio of 24.02, a PEG ratio of 1.98 and a beta of 0.86. The stock has a 50 day moving average of $69.99 and a 200-day moving average of $69.92.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping the consensus estimate of $1.22 by $0.01. The business had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter last year, the company posted $1.31 earnings per share.

Institutional Investors Weigh In On Henry Schein

A number of institutional investors have recently added to or reduced their stakes in the company. Summit Securities Group LLC acquired a new position in shares of Henry Schein during the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA bought a new position in Henry Schein during the second quarter valued at about $37,000. Blue Trust Inc. grew its holdings in Henry Schein by 104.2% during the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after acquiring an additional 475 shares during the period. Mather Group LLC. raised its position in Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock worth $96,000 after acquiring an additional 216 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.